Jasper Therapeutics (JSPR) PT Lowered to $60 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts JSPR Hot Sheet
Price: $0.82 -7.87%
Rating Summary:
10 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
10 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
H.C. Wainwright analyst Emily Bodnar lowered the price target on Jasper Therapeutics (NASDAQ: JSPR) to $60.00 (from $65.00) while maintaining a Buy rating.
You May Also Be Interested In
- Piper Sandler Starts Jasper Therapeutics (JSPR) at Overweight
- Workman Co Ltd (7564:JP) (WKISF) PT Lowered to JPY8,100 at Nomura/Instinet
- Madison Square Garden Entertainment (MSGE) PT Raised to $103 at Guggenheim
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
